Clinical Trial Update: Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating platelet-rich plasma to reduce alveolar bone resorption during rapid maxillary expansion has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss
• Bone Resorption

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Damascus University | Conditions: Bone Resorption | Phase 1 | Status: COMPLETED